nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—Organic Cation Transporter 2 Inhibitors—Crizotinib—lung cancer	0.44	0.562	CiPCiCtD
Ranolazine—Cytochrome P450 3A Inhibitors—Crizotinib—lung cancer	0.211	0.27	CiPCiCtD
Ranolazine—P-Glycoprotein Inhibitors—Crizotinib—lung cancer	0.132	0.169	CiPCiCtD
Ranolazine—CYP2D6—Gefitinib—lung cancer	0.0147	0.125	CbGbCtD
Ranolazine—CYP2D6—Vinorelbine—lung cancer	0.0113	0.096	CbGbCtD
Ranolazine—CYP3A4—Topotecan—lung cancer	0.0102	0.0866	CbGbCtD
Ranolazine—CYP3A4—Gefitinib—lung cancer	0.00935	0.0792	CbGbCtD
Ranolazine—CYP3A4—Teniposide—lung cancer	0.00906	0.0768	CbGbCtD
Ranolazine—CYP2D6—Erlotinib—lung cancer	0.00869	0.0737	CbGbCtD
Ranolazine—CYP3A4—Vinorelbine—lung cancer	0.0072	0.061	CbGbCtD
Ranolazine—CYP2D6—Vinblastine—lung cancer	0.00698	0.0592	CbGbCtD
Ranolazine—CYP3A4—Crizotinib—lung cancer	0.00573	0.0486	CbGbCtD
Ranolazine—CYP3A4—Erlotinib—lung cancer	0.00553	0.0469	CbGbCtD
Ranolazine—CYP3A4—Paclitaxel—lung cancer	0.00506	0.0429	CbGbCtD
Ranolazine—CYP3A4—Irinotecan—lung cancer	0.00499	0.0423	CbGbCtD
Ranolazine—CYP3A4—Vinblastine—lung cancer	0.00444	0.0376	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—lung cancer	0.00429	0.0364	CbGbCtD
Ranolazine—CYP3A4—Etoposide—lung cancer	0.004	0.0339	CbGbCtD
Ranolazine—CYP3A4—Docetaxel—lung cancer	0.00366	0.031	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—lung cancer	0.00273	0.0231	CbGbCtD
Ranolazine—Carvedilol—HIF1A—lung cancer	0.00059	0.471	CrCbGaD
Ranolazine—Carvedilol—VEGFA—lung cancer	0.000238	0.19	CrCbGaD
Ranolazine—Carvedilol—CYP2E1—lung cancer	0.000116	0.0928	CrCbGaD
Ranolazine—Carvedilol—CYP1A1—lung cancer	0.000115	0.0915	CrCbGaD
Ranolazine—Propranolol—CYP1A1—lung cancer	8.73e-05	0.0696	CrCbGaD
Ranolazine—Carvedilol—ABCB1—lung cancer	6.1e-05	0.0486	CrCbGaD
Ranolazine—Anxiety—Paclitaxel—lung cancer	5.81e-05	0.000762	CcSEcCtD
Ranolazine—Malnutrition—Docetaxel—lung cancer	5.8e-05	0.000761	CcSEcCtD
Ranolazine—Decreased appetite—Gemcitabine—lung cancer	5.8e-05	0.000761	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	5.79e-05	0.000759	CcSEcCtD
Ranolazine—Nausea—Topotecan—lung cancer	5.77e-05	0.000756	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Gemcitabine—lung cancer	5.76e-05	0.000755	CcSEcCtD
Ranolazine—Abdominal discomfort—Methotrexate—lung cancer	5.75e-05	0.000754	CcSEcCtD
Ranolazine—Fatigue—Gemcitabine—lung cancer	5.75e-05	0.000754	CcSEcCtD
Ranolazine—Confusional state—Etoposide—lung cancer	5.74e-05	0.000753	CcSEcCtD
Ranolazine—Constipation—Gemcitabine—lung cancer	5.71e-05	0.000748	CcSEcCtD
Ranolazine—Nausea—Erlotinib—lung cancer	5.71e-05	0.000748	CcSEcCtD
Ranolazine—Pancytopenia—Methotrexate—lung cancer	5.7e-05	0.000747	CcSEcCtD
Ranolazine—Dry mouth—Paclitaxel—lung cancer	5.7e-05	0.000747	CcSEcCtD
Ranolazine—Feeling abnormal—Irinotecan—lung cancer	5.64e-05	0.00074	CcSEcCtD
Ranolazine—Confusional state—Paclitaxel—lung cancer	5.63e-05	0.000739	CcSEcCtD
Ranolazine—Blood creatinine increased—Doxorubicin—lung cancer	5.63e-05	0.000739	CcSEcCtD
Ranolazine—Dysuria—Methotrexate—lung cancer	5.61e-05	0.000736	CcSEcCtD
Ranolazine—Gastrointestinal pain—Irinotecan—lung cancer	5.6e-05	0.000735	CcSEcCtD
Ranolazine—Dehydration—Doxorubicin—lung cancer	5.59e-05	0.000733	CcSEcCtD
Ranolazine—Paraesthesia—Cisplatin—lung cancer	5.58e-05	0.000732	CcSEcCtD
Ranolazine—Thrombocytopenia—Etoposide—lung cancer	5.58e-05	0.000732	CcSEcCtD
Ranolazine—Muscle spasms—Docetaxel—lung cancer	5.58e-05	0.000731	CcSEcCtD
Ranolazine—Dyspnoea—Cisplatin—lung cancer	5.54e-05	0.000727	CcSEcCtD
Ranolazine—Skin disorder—Etoposide—lung cancer	5.53e-05	0.000726	CcSEcCtD
Ranolazine—Erectile dysfunction—Methotrexate—lung cancer	5.53e-05	0.000725	CcSEcCtD
Ranolazine—Hyperhidrosis—Etoposide—lung cancer	5.51e-05	0.000722	CcSEcCtD
Ranolazine—Feeling abnormal—Gemcitabine—lung cancer	5.5e-05	0.000721	CcSEcCtD
Ranolazine—Shock—Paclitaxel—lung cancer	5.5e-05	0.000721	CcSEcCtD
Ranolazine—Dizziness—Vinorelbine—lung cancer	5.49e-05	0.00072	CcSEcCtD
Ranolazine—Orthostatic hypotension—Doxorubicin—lung cancer	5.49e-05	0.00072	CcSEcCtD
Ranolazine—Nervous system disorder—Paclitaxel—lung cancer	5.48e-05	0.000718	CcSEcCtD
Ranolazine—Thrombocytopenia—Paclitaxel—lung cancer	5.47e-05	0.000717	CcSEcCtD
Ranolazine—Breast disorder—Doxorubicin—lung cancer	5.43e-05	0.000713	CcSEcCtD
Ranolazine—Anorexia—Etoposide—lung cancer	5.43e-05	0.000712	CcSEcCtD
Ranolazine—Skin disorder—Paclitaxel—lung cancer	5.43e-05	0.000712	CcSEcCtD
Ranolazine—Abdominal pain—Irinotecan—lung cancer	5.41e-05	0.00071	CcSEcCtD
Ranolazine—Decreased appetite—Cisplatin—lung cancer	5.41e-05	0.000709	CcSEcCtD
Ranolazine—Hyperhidrosis—Paclitaxel—lung cancer	5.4e-05	0.000708	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Cisplatin—lung cancer	5.37e-05	0.000704	CcSEcCtD
Ranolazine—Anorexia—Paclitaxel—lung cancer	5.33e-05	0.000698	CcSEcCtD
Ranolazine—Hypotension—Etoposide—lung cancer	5.32e-05	0.000698	CcSEcCtD
Ranolazine—Vomiting—Vinorelbine—lung cancer	5.28e-05	0.000693	CcSEcCtD
Ranolazine—Renal failure—Methotrexate—lung cancer	5.26e-05	0.00069	CcSEcCtD
Ranolazine—Rash—Vinorelbine—lung cancer	5.24e-05	0.000687	CcSEcCtD
Ranolazine—Dermatitis—Vinorelbine—lung cancer	5.23e-05	0.000686	CcSEcCtD
Ranolazine—Hypotension—Paclitaxel—lung cancer	5.22e-05	0.000685	CcSEcCtD
Ranolazine—Headache—Vinorelbine—lung cancer	5.2e-05	0.000682	CcSEcCtD
Ranolazine—Syncope—Docetaxel—lung cancer	5.2e-05	0.000682	CcSEcCtD
Ranolazine—Leukopenia—Docetaxel—lung cancer	5.19e-05	0.000681	CcSEcCtD
Ranolazine—Eosinophilia—Doxorubicin—lung cancer	5.15e-05	0.000675	CcSEcCtD
Ranolazine—Palpitations—Docetaxel—lung cancer	5.13e-05	0.000672	CcSEcCtD
Ranolazine—Feeling abnormal—Cisplatin—lung cancer	5.12e-05	0.000672	CcSEcCtD
Ranolazine—Paraesthesia—Etoposide—lung cancer	5.12e-05	0.000671	CcSEcCtD
Ranolazine—Haematuria—Methotrexate—lung cancer	5.1e-05	0.000669	CcSEcCtD
Ranolazine—Loss of consciousness—Docetaxel—lung cancer	5.1e-05	0.000669	CcSEcCtD
Ranolazine—Pancreatitis—Doxorubicin—lung cancer	5.09e-05	0.000668	CcSEcCtD
Ranolazine—Dyspnoea—Etoposide—lung cancer	5.08e-05	0.000666	CcSEcCtD
Ranolazine—Somnolence—Etoposide—lung cancer	5.07e-05	0.000664	CcSEcCtD
Ranolazine—Cough—Docetaxel—lung cancer	5.06e-05	0.000664	CcSEcCtD
Ranolazine—Insomnia—Paclitaxel—lung cancer	5.05e-05	0.000663	CcSEcCtD
Ranolazine—Epistaxis—Methotrexate—lung cancer	5.05e-05	0.000662	CcSEcCtD
Ranolazine—Paraesthesia—Paclitaxel—lung cancer	5.02e-05	0.000658	CcSEcCtD
Ranolazine—Dyspnoea—Paclitaxel—lung cancer	4.98e-05	0.000653	CcSEcCtD
Ranolazine—Somnolence—Paclitaxel—lung cancer	4.97e-05	0.000651	CcSEcCtD
Ranolazine—Decreased appetite—Etoposide—lung cancer	4.95e-05	0.00065	CcSEcCtD
Ranolazine—Pancytopenia—Doxorubicin—lung cancer	4.94e-05	0.000647	CcSEcCtD
Ranolazine—Nausea—Vinorelbine—lung cancer	4.93e-05	0.000647	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Etoposide—lung cancer	4.92e-05	0.000645	CcSEcCtD
Ranolazine—Dyspepsia—Paclitaxel—lung cancer	4.92e-05	0.000645	CcSEcCtD
Ranolazine—Asthenia—Irinotecan—lung cancer	4.91e-05	0.000644	CcSEcCtD
Ranolazine—Fatigue—Etoposide—lung cancer	4.91e-05	0.000644	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	4.91e-05	0.000643	CcSEcCtD
Ranolazine—Constipation—Etoposide—lung cancer	4.87e-05	0.000639	CcSEcCtD
Ranolazine—Dysuria—Doxorubicin—lung cancer	4.86e-05	0.000637	CcSEcCtD
Ranolazine—Decreased appetite—Paclitaxel—lung cancer	4.86e-05	0.000637	CcSEcCtD
Ranolazine—Dry mouth—Docetaxel—lung cancer	4.83e-05	0.000633	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Paclitaxel—lung cancer	4.82e-05	0.000632	CcSEcCtD
Ranolazine—Fatigue—Paclitaxel—lung cancer	4.82e-05	0.000632	CcSEcCtD
Ranolazine—Asthenia—Gemcitabine—lung cancer	4.79e-05	0.000628	CcSEcCtD
Ranolazine—Constipation—Paclitaxel—lung cancer	4.78e-05	0.000626	CcSEcCtD
Ranolazine—Confusional state—Docetaxel—lung cancer	4.77e-05	0.000626	CcSEcCtD
Ranolazine—Urinary tract disorder—Methotrexate—lung cancer	4.74e-05	0.000622	CcSEcCtD
Ranolazine—Pruritus—Gemcitabine—lung cancer	4.72e-05	0.000619	CcSEcCtD
Ranolazine—Urethral disorder—Methotrexate—lung cancer	4.71e-05	0.000617	CcSEcCtD
Ranolazine—Weight decreased—Doxorubicin—lung cancer	4.7e-05	0.000617	CcSEcCtD
Ranolazine—Feeling abnormal—Etoposide—lung cancer	4.7e-05	0.000616	CcSEcCtD
Ranolazine—Gastrointestinal pain—Etoposide—lung cancer	4.66e-05	0.000611	CcSEcCtD
Ranolazine—Shock—Docetaxel—lung cancer	4.66e-05	0.000611	CcSEcCtD
Ranolazine—Nervous system disorder—Docetaxel—lung cancer	4.64e-05	0.000609	CcSEcCtD
Ranolazine—Propranolol—ABCB1—lung cancer	4.64e-05	0.037	CrCbGaD
Ranolazine—Thrombocytopenia—Docetaxel—lung cancer	4.64e-05	0.000608	CcSEcCtD
Ranolazine—Visual impairment—Methotrexate—lung cancer	4.63e-05	0.000607	CcSEcCtD
Ranolazine—Feeling abnormal—Paclitaxel—lung cancer	4.6e-05	0.000604	CcSEcCtD
Ranolazine—Skin disorder—Docetaxel—lung cancer	4.6e-05	0.000603	CcSEcCtD
Ranolazine—Gastrointestinal pain—Paclitaxel—lung cancer	4.57e-05	0.000599	CcSEcCtD
Ranolazine—Renal failure—Doxorubicin—lung cancer	4.55e-05	0.000597	CcSEcCtD
Ranolazine—Dizziness—Irinotecan—lung cancer	4.53e-05	0.000594	CcSEcCtD
Ranolazine—Urticaria—Etoposide—lung cancer	4.53e-05	0.000594	CcSEcCtD
Ranolazine—Anorexia—Docetaxel—lung cancer	4.51e-05	0.000592	CcSEcCtD
Ranolazine—Abdominal pain—Etoposide—lung cancer	4.5e-05	0.000591	CcSEcCtD
Ranolazine—Eye disorder—Methotrexate—lung cancer	4.49e-05	0.000589	CcSEcCtD
Ranolazine—Tinnitus—Methotrexate—lung cancer	4.48e-05	0.000587	CcSEcCtD
Ranolazine—Asthenia—Cisplatin—lung cancer	4.46e-05	0.000585	CcSEcCtD
Ranolazine—Cardiac disorder—Methotrexate—lung cancer	4.46e-05	0.000585	CcSEcCtD
Ranolazine—Urticaria—Paclitaxel—lung cancer	4.44e-05	0.000582	CcSEcCtD
Ranolazine—Hypotension—Docetaxel—lung cancer	4.42e-05	0.00058	CcSEcCtD
Ranolazine—Haematuria—Doxorubicin—lung cancer	4.42e-05	0.000579	CcSEcCtD
Ranolazine—Abdominal pain—Paclitaxel—lung cancer	4.42e-05	0.000579	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—lung cancer	4.37e-05	0.000573	CcSEcCtD
Ranolazine—Angiopathy—Methotrexate—lung cancer	4.36e-05	0.000572	CcSEcCtD
Ranolazine—Vomiting—Irinotecan—lung cancer	4.36e-05	0.000571	CcSEcCtD
Ranolazine—Mediastinal disorder—Methotrexate—lung cancer	4.33e-05	0.000568	CcSEcCtD
Ranolazine—Rash—Irinotecan—lung cancer	4.32e-05	0.000566	CcSEcCtD
Ranolazine—Dermatitis—Irinotecan—lung cancer	4.31e-05	0.000566	CcSEcCtD
Ranolazine—Headache—Irinotecan—lung cancer	4.29e-05	0.000563	CcSEcCtD
Ranolazine—Insomnia—Docetaxel—lung cancer	4.28e-05	0.000562	CcSEcCtD
Ranolazine—Paraesthesia—Docetaxel—lung cancer	4.25e-05	0.000558	CcSEcCtD
Ranolazine—Vomiting—Gemcitabine—lung cancer	4.24e-05	0.000556	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—lung cancer	4.23e-05	0.000555	CcSEcCtD
Ranolazine—Dyspnoea—Docetaxel—lung cancer	4.22e-05	0.000554	CcSEcCtD
Ranolazine—Somnolence—Docetaxel—lung cancer	4.21e-05	0.000552	CcSEcCtD
Ranolazine—Mental disorder—Methotrexate—lung cancer	4.21e-05	0.000552	CcSEcCtD
Ranolazine—Rash—Gemcitabine—lung cancer	4.21e-05	0.000552	CcSEcCtD
Ranolazine—Dermatitis—Gemcitabine—lung cancer	4.2e-05	0.000551	CcSEcCtD
Ranolazine—Malnutrition—Methotrexate—lung cancer	4.18e-05	0.000548	CcSEcCtD
Ranolazine—Headache—Gemcitabine—lung cancer	4.18e-05	0.000548	CcSEcCtD
Ranolazine—Dyspepsia—Docetaxel—lung cancer	4.17e-05	0.000547	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—lung cancer	4.14e-05	0.000543	CcSEcCtD
Ranolazine—Decreased appetite—Docetaxel—lung cancer	4.12e-05	0.00054	CcSEcCtD
Ranolazine—Urinary tract disorder—Doxorubicin—lung cancer	4.11e-05	0.000539	CcSEcCtD
Ranolazine—Oedema peripheral—Doxorubicin—lung cancer	4.1e-05	0.000537	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Docetaxel—lung cancer	4.09e-05	0.000536	CcSEcCtD
Ranolazine—Asthenia—Etoposide—lung cancer	4.09e-05	0.000536	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—lung cancer	4.09e-05	0.000536	CcSEcCtD
Ranolazine—Fatigue—Docetaxel—lung cancer	4.08e-05	0.000535	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—lung cancer	4.08e-05	0.000535	CcSEcCtD
Ranolazine—Nausea—Irinotecan—lung cancer	4.07e-05	0.000534	CcSEcCtD
Ranolazine—Constipation—Docetaxel—lung cancer	4.05e-05	0.000531	CcSEcCtD
Ranolazine—Pruritus—Etoposide—lung cancer	4.03e-05	0.000529	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—lung cancer	4.01e-05	0.000526	CcSEcCtD
Ranolazine—Asthenia—Paclitaxel—lung cancer	4.01e-05	0.000526	CcSEcCtD
Ranolazine—Nausea—Gemcitabine—lung cancer	3.96e-05	0.00052	CcSEcCtD
Ranolazine—Vomiting—Cisplatin—lung cancer	3.95e-05	0.000519	CcSEcCtD
Ranolazine—Pruritus—Paclitaxel—lung cancer	3.95e-05	0.000518	CcSEcCtD
Ranolazine—Vision blurred—Methotrexate—lung cancer	3.94e-05	0.000517	CcSEcCtD
Ranolazine—Rash—Cisplatin—lung cancer	3.92e-05	0.000514	CcSEcCtD
Ranolazine—Dermatitis—Cisplatin—lung cancer	3.92e-05	0.000514	CcSEcCtD
Ranolazine—Feeling abnormal—Docetaxel—lung cancer	3.9e-05	0.000512	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—lung cancer	3.89e-05	0.00051	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—lung cancer	3.88e-05	0.000509	CcSEcCtD
Ranolazine—Gastrointestinal pain—Docetaxel—lung cancer	3.87e-05	0.000508	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—lung cancer	3.86e-05	0.000506	CcSEcCtD
Ranolazine—Angiopathy—Doxorubicin—lung cancer	3.77e-05	0.000495	CcSEcCtD
Ranolazine—Dizziness—Etoposide—lung cancer	3.77e-05	0.000494	CcSEcCtD
Ranolazine—Vertigo—Methotrexate—lung cancer	3.76e-05	0.000493	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—lung cancer	3.75e-05	0.000492	CcSEcCtD
Ranolazine—Abdominal pain—Docetaxel—lung cancer	3.74e-05	0.000491	CcSEcCtD
Ranolazine—Leukopenia—Methotrexate—lung cancer	3.74e-05	0.000491	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—lung cancer	3.72e-05	0.000487	CcSEcCtD
Ranolazine—Dizziness—Paclitaxel—lung cancer	3.69e-05	0.000484	CcSEcCtD
Ranolazine—Nausea—Cisplatin—lung cancer	3.69e-05	0.000484	CcSEcCtD
Ranolazine—Cough—Methotrexate—lung cancer	3.65e-05	0.000479	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—lung cancer	3.64e-05	0.000478	CcSEcCtD
Ranolazine—SCN5A—L1CAM interactions—EGFR—lung cancer	3.64e-05	0.00174	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP2—lung cancer	3.64e-05	0.00173	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MAP2K1—lung cancer	3.63e-05	0.00173	CbGpPWpGaD
Ranolazine—Vomiting—Etoposide—lung cancer	3.62e-05	0.000475	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—lung cancer	3.62e-05	0.000475	CcSEcCtD
Ranolazine—Rash—Etoposide—lung cancer	3.59e-05	0.000471	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—lung cancer	3.59e-05	0.000471	CcSEcCtD
Ranolazine—Headache—Etoposide—lung cancer	3.57e-05	0.000468	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—lung cancer	3.57e-05	0.000468	CcSEcCtD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	3.57e-05	0.0017	CbGpPWpGaD
Ranolazine—Vomiting—Paclitaxel—lung cancer	3.55e-05	0.000466	CcSEcCtD
Ranolazine—CYP3A4—Tryptophan metabolism—CAT—lung cancer	3.54e-05	0.00169	CbGpPWpGaD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.54e-05	0.000464	CcSEcCtD
Ranolazine—Rash—Paclitaxel—lung cancer	3.52e-05	0.000462	CcSEcCtD
Ranolazine—Dermatitis—Paclitaxel—lung cancer	3.52e-05	0.000461	CcSEcCtD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	3.52e-05	0.00168	CbGpPWpGaD
Ranolazine—Headache—Paclitaxel—lung cancer	3.5e-05	0.000459	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—lung cancer	3.48e-05	0.000457	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—AKR1C1—lung cancer	3.44e-05	0.00164	CbGpPWpGaD
Ranolazine—Confusional state—Methotrexate—lung cancer	3.44e-05	0.000451	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—CNDP2—lung cancer	3.44e-05	0.00164	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM2—lung cancer	3.44e-05	0.00164	CbGpPWpGaD
Ranolazine—Vision blurred—Doxorubicin—lung cancer	3.41e-05	0.000447	CcSEcCtD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	3.4e-05	0.00162	CbGpPWpGaD
Ranolazine—Asthenia—Docetaxel—lung cancer	3.4e-05	0.000446	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	3.39e-05	0.00162	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—UGT1A1—lung cancer	3.39e-05	0.00161	CbGpPWpGaD
Ranolazine—Nausea—Etoposide—lung cancer	3.38e-05	0.000444	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CXCL8—lung cancer	3.38e-05	0.00161	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—FGFR1—lung cancer	3.38e-05	0.00161	CbGpPWpGaD
Ranolazine—Pruritus—Docetaxel—lung cancer	3.35e-05	0.000439	CcSEcCtD
Ranolazine—Nervous system disorder—Methotrexate—lung cancer	3.35e-05	0.000439	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—UGT1A1—lung cancer	3.34e-05	0.00159	CbGpPWpGaD
Ranolazine—Thrombocytopenia—Methotrexate—lung cancer	3.34e-05	0.000438	CcSEcCtD
Ranolazine—Nausea—Paclitaxel—lung cancer	3.32e-05	0.000435	CcSEcCtD
Ranolazine—Skin disorder—Methotrexate—lung cancer	3.31e-05	0.000435	CcSEcCtD
Ranolazine—Hyperhidrosis—Methotrexate—lung cancer	3.3e-05	0.000433	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—lung cancer	3.25e-05	0.000427	CcSEcCtD
Ranolazine—Anorexia—Methotrexate—lung cancer	3.25e-05	0.000427	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—lung cancer	3.25e-05	0.000426	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—lung cancer	3.24e-05	0.000425	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CASP3—lung cancer	3.23e-05	0.00154	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—RAF1—lung cancer	3.22e-05	0.00154	CbGpPWpGaD
Ranolazine—Palpitations—Doxorubicin—lung cancer	3.2e-05	0.00042	CcSEcCtD
Ranolazine—Hypotension—Methotrexate—lung cancer	3.19e-05	0.000418	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—ERBB2—lung cancer	3.19e-05	0.00152	CbGpPWpGaD
Ranolazine—Loss of consciousness—Doxorubicin—lung cancer	3.18e-05	0.000417	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—KDR—lung cancer	3.18e-05	0.00152	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	3.18e-05	0.00151	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	3.17e-05	0.00151	CbGpPWpGaD
Ranolazine—Cough—Doxorubicin—lung cancer	3.16e-05	0.000414	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—JUN—lung cancer	3.14e-05	0.0015	CbGpPWpGaD
Ranolazine—Dizziness—Docetaxel—lung cancer	3.13e-05	0.000411	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—MET—lung cancer	3.11e-05	0.00148	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2A7—lung cancer	3.11e-05	0.00148	CbGpPWpGaD
Ranolazine—Insomnia—Methotrexate—lung cancer	3.09e-05	0.000405	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—lung cancer	3.07e-05	0.000403	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	3.07e-05	0.00146	CbGpPWpGaD
Ranolazine—Paraesthesia—Methotrexate—lung cancer	3.06e-05	0.000402	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.06e-05	0.000401	CcSEcCtD
Ranolazine—Dyspnoea—Methotrexate—lung cancer	3.04e-05	0.000399	CcSEcCtD
Ranolazine—Somnolence—Methotrexate—lung cancer	3.03e-05	0.000398	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—lung cancer	3.01e-05	0.000395	CcSEcCtD
Ranolazine—Vomiting—Docetaxel—lung cancer	3.01e-05	0.000395	CcSEcCtD
Ranolazine—Dyspepsia—Methotrexate—lung cancer	3e-05	0.000394	CcSEcCtD
Ranolazine—Rash—Docetaxel—lung cancer	2.99e-05	0.000392	CcSEcCtD
Ranolazine—Dermatitis—Docetaxel—lung cancer	2.98e-05	0.000391	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—lung cancer	2.98e-05	0.000391	CcSEcCtD
Ranolazine—Decreased appetite—Methotrexate—lung cancer	2.97e-05	0.000389	CcSEcCtD
Ranolazine—Headache—Docetaxel—lung cancer	2.97e-05	0.000389	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—FGFR1—lung cancer	2.95e-05	0.0014	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Methotrexate—lung cancer	2.95e-05	0.000386	CcSEcCtD
Ranolazine—Fatigue—Methotrexate—lung cancer	2.94e-05	0.000386	CcSEcCtD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	2.92e-05	0.00139	CbGpPWpGaD
Ranolazine—Shock—Doxorubicin—lung cancer	2.91e-05	0.000381	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—lung cancer	2.9e-05	0.00038	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—EP300—lung cancer	2.9e-05	0.00138	CbGpPWpGaD
Ranolazine—Thrombocytopenia—Doxorubicin—lung cancer	2.89e-05	0.000379	CcSEcCtD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	2.89e-05	0.00138	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—HPGDS—lung cancer	2.88e-05	0.00137	CbGpPWpGaD
Ranolazine—Skin disorder—Doxorubicin—lung cancer	2.87e-05	0.000376	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—lung cancer	2.86e-05	0.000375	CcSEcCtD
Ranolazine—Anorexia—Doxorubicin—lung cancer	2.82e-05	0.000369	CcSEcCtD
Ranolazine—Nausea—Docetaxel—lung cancer	2.81e-05	0.000369	CcSEcCtD
Ranolazine—Feeling abnormal—Methotrexate—lung cancer	2.81e-05	0.000369	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—GSTT1—lung cancer	2.79e-05	0.00133	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Methotrexate—lung cancer	2.79e-05	0.000366	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—FOXO3—lung cancer	2.79e-05	0.00133	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KDR—lung cancer	2.78e-05	0.00132	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTA3—lung cancer	2.77e-05	0.00132	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GCLC—lung cancer	2.76e-05	0.00132	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP2A6—lung cancer	2.76e-05	0.00132	CbGpPWpGaD
Ranolazine—Hypotension—Doxorubicin—lung cancer	2.76e-05	0.000362	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—lung cancer	2.74e-05	0.00131	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MMP9—lung cancer	2.73e-05	0.0013	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	2.73e-05	0.0013	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6R—lung cancer	2.72e-05	0.0013	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MET—lung cancer	2.72e-05	0.00129	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CREBBP—lung cancer	2.72e-05	0.00129	CbGpPWpGaD
Ranolazine—Urticaria—Methotrexate—lung cancer	2.71e-05	0.000356	CcSEcCtD
Ranolazine—Abdominal pain—Methotrexate—lung cancer	2.7e-05	0.000354	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—ITGB1—lung cancer	2.69e-05	0.00128	CbGpPWpGaD
Ranolazine—Insomnia—Doxorubicin—lung cancer	2.67e-05	0.000351	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—lung cancer	2.65e-05	0.000348	CcSEcCtD
Ranolazine—Dyspnoea—Doxorubicin—lung cancer	2.63e-05	0.000345	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—lung cancer	2.63e-05	0.000345	CcSEcCtD
Ranolazine—Dyspepsia—Doxorubicin—lung cancer	2.6e-05	0.000341	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—MMP2—lung cancer	2.6e-05	0.00124	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAP2K1—lung cancer	2.59e-05	0.00124	CbGpPWpGaD
Ranolazine—Decreased appetite—Doxorubicin—lung cancer	2.57e-05	0.000337	CcSEcCtD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	2.56e-05	0.00122	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Doxorubicin—lung cancer	2.55e-05	0.000335	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—lung cancer	2.55e-05	0.000334	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—GSTA4—lung cancer	2.53e-05	0.00121	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	2.53e-05	0.0012	CbGpPWpGaD
Ranolazine—Constipation—Doxorubicin—lung cancer	2.53e-05	0.000331	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—SRC—lung cancer	2.52e-05	0.0012	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	2.5e-05	0.00119	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HES1—lung cancer	2.47e-05	0.00118	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTA2—lung cancer	2.47e-05	0.00118	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—lung cancer	2.45e-05	0.00117	CbGpPWpGaD
Ranolazine—Asthenia—Methotrexate—lung cancer	2.45e-05	0.000321	CcSEcCtD
Ranolazine—Feeling abnormal—Doxorubicin—lung cancer	2.44e-05	0.000319	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—NRAS—lung cancer	2.42e-05	0.00116	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Doxorubicin—lung cancer	2.42e-05	0.000317	CcSEcCtD
Ranolazine—Pruritus—Methotrexate—lung cancer	2.41e-05	0.000317	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—GSTA1—lung cancer	2.38e-05	0.00114	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6R—lung cancer	2.37e-05	0.00113	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—lung cancer	2.37e-05	0.00113	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP2E1—lung cancer	2.35e-05	0.00112	CbGpPWpGaD
Ranolazine—Urticaria—Doxorubicin—lung cancer	2.35e-05	0.000308	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—lung cancer	2.34e-05	0.000306	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—MAPK3—lung cancer	2.32e-05	0.00111	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP2E1—lung cancer	2.32e-05	0.0011	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—RAF1—lung cancer	2.3e-05	0.0011	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ERBB2—lung cancer	2.27e-05	0.00108	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP2—lung cancer	2.27e-05	0.00108	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAP2K1—lung cancer	2.26e-05	0.00108	CbGpPWpGaD
Ranolazine—Dizziness—Methotrexate—lung cancer	2.26e-05	0.000296	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	2.25e-05	0.00107	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—UGT1A1—lung cancer	2.22e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—EGFR—lung cancer	2.21e-05	0.00105	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	2.18e-05	0.00104	CbGpPWpGaD
Ranolazine—Vomiting—Methotrexate—lung cancer	2.17e-05	0.000285	CcSEcCtD
Ranolazine—Rash—Methotrexate—lung cancer	2.15e-05	0.000282	CcSEcCtD
Ranolazine—Dermatitis—Methotrexate—lung cancer	2.15e-05	0.000282	CcSEcCtD
Ranolazine—Headache—Methotrexate—lung cancer	2.14e-05	0.00028	CcSEcCtD
Ranolazine—Asthenia—Doxorubicin—lung cancer	2.12e-05	0.000278	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—FGFR1—lung cancer	2.1e-05	0.001	CbGpPWpGaD
Ranolazine—Pruritus—Doxorubicin—lung cancer	2.09e-05	0.000274	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—KRAS—lung cancer	2.09e-05	0.000994	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	2.08e-05	0.00099	CbGpPWpGaD
Ranolazine—Nausea—Methotrexate—lung cancer	2.03e-05	0.000266	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—RAF1—lung cancer	2.01e-05	0.000956	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ERBB2—lung cancer	1.99e-05	0.000946	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KDR—lung cancer	1.98e-05	0.000944	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	1.95e-05	0.000931	CbGpPWpGaD
Ranolazine—Dizziness—Doxorubicin—lung cancer	1.95e-05	0.000256	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—MMP9—lung cancer	1.95e-05	0.00093	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MET—lung cancer	1.94e-05	0.000924	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTP1—lung cancer	1.94e-05	0.000923	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	1.91e-05	0.00091	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	1.91e-05	0.00091	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—lung cancer	1.9e-05	0.000904	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—HPGDS—lung cancer	1.88e-05	0.000898	CbGpPWpGaD
Ranolazine—Vomiting—Doxorubicin—lung cancer	1.88e-05	0.000246	CcSEcCtD
Ranolazine—Rash—Doxorubicin—lung cancer	1.86e-05	0.000244	CcSEcCtD
Ranolazine—Dermatitis—Doxorubicin—lung cancer	1.86e-05	0.000244	CcSEcCtD
Ranolazine—Headache—Doxorubicin—lung cancer	1.85e-05	0.000243	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—EP300—lung cancer	1.85e-05	0.000881	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTT1—lung cancer	1.83e-05	0.000871	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GCLC—lung cancer	1.81e-05	0.00086	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	1.81e-05	0.00086	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—SRC—lung cancer	1.8e-05	0.000857	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTM1—lung cancer	1.78e-05	0.000848	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—HRAS—lung cancer	1.77e-05	0.000845	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	1.76e-05	0.000836	CbGpPWpGaD
Ranolazine—Nausea—Doxorubicin—lung cancer	1.76e-05	0.00023	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—VEGFA—lung cancer	1.75e-05	0.000835	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—STAT3—lung cancer	1.73e-05	0.000827	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NRAS—lung cancer	1.73e-05	0.000825	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MMP9—lung cancer	1.7e-05	0.000812	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—lung cancer	1.7e-05	0.000809	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6R—lung cancer	1.69e-05	0.000807	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CREBBP—lung cancer	1.69e-05	0.000806	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	1.69e-05	0.000804	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	1.66e-05	0.000793	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAPK3—lung cancer	1.66e-05	0.00079	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP2—lung cancer	1.62e-05	0.00077	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAP2K1—lung cancer	1.61e-05	0.000769	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EGFR—lung cancer	1.58e-05	0.000751	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—SRC—lung cancer	1.57e-05	0.000748	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	1.55e-05	0.000738	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	1.54e-05	0.000732	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—lung cancer	1.53e-05	0.000729	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	1.51e-05	0.000722	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—NRAS—lung cancer	1.51e-05	0.00072	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KRAS—lung cancer	1.49e-05	0.00071	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—COL4A3BP—lung cancer	1.48e-05	0.000707	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AZIN2—lung cancer	1.48e-05	0.000707	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MAPK3—lung cancer	1.45e-05	0.000689	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAF1—lung cancer	1.43e-05	0.000682	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ERBB2—lung cancer	1.42e-05	0.000675	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—EGFR—lung cancer	1.38e-05	0.000656	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—KRAS—lung cancer	1.3e-05	0.00062	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTP1—lung cancer	1.27e-05	0.000603	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HRAS—lung cancer	1.27e-05	0.000603	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ATP5H—lung cancer	1.26e-05	0.000601	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—POMC—lung cancer	1.26e-05	0.000599	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	1.25e-05	0.000595	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MMP9—lung cancer	1.22e-05	0.000579	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—lung cancer	1.21e-05	0.000577	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM1—lung cancer	1.16e-05	0.000554	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EP300—lung cancer	1.15e-05	0.000549	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	1.15e-05	0.000547	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PLBD1—lung cancer	1.12e-05	0.000536	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SRC—lung cancer	1.12e-05	0.000534	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—lung cancer	1.12e-05	0.000533	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—HRAS—lung cancer	1.11e-05	0.000527	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	1.1e-05	0.000526	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—lung cancer	1.09e-05	0.00052	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	1.09e-05	0.000518	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—STAT3—lung cancer	1.08e-05	0.000515	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NRAS—lung cancer	1.08e-05	0.000514	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—lung cancer	1.06e-05	0.000504	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAPK3—lung cancer	1.03e-05	0.000492	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD17B10—lung cancer	1.03e-05	0.00049	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EGFR—lung cancer	9.82e-06	0.000468	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—COL4A3BP—lung cancer	9.7e-06	0.000462	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AZIN2—lung cancer	9.7e-06	0.000462	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CKB—lung cancer	9.56e-06	0.000456	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KRAS—lung cancer	9.28e-06	0.000442	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM2—lung cancer	8.99e-06	0.000428	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CNDP2—lung cancer	8.99e-06	0.000428	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTMR3—lung cancer	8.75e-06	0.000417	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PGAM1—lung cancer	8.52e-06	0.000406	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ATP5H—lung cancer	8.25e-06	0.000393	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—POMC—lung cancer	8.22e-06	0.000392	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2A7—lung cancer	8.13e-06	0.000387	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SDC4—lung cancer	7.96e-06	0.000379	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HRAS—lung cancer	7.89e-06	0.000376	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—lung cancer	7.55e-06	0.00036	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PLBD1—lung cancer	7.35e-06	0.00035	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—RRM1—lung cancer	7.25e-06	0.000345	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA3—lung cancer	7.25e-06	0.000345	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—lung cancer	6.96e-06	0.000332	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—B4GALT5—lung cancer	6.81e-06	0.000325	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD17B10—lung cancer	6.73e-06	0.00032	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA4—lung cancer	6.63e-06	0.000316	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA2—lung cancer	6.46e-06	0.000308	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CKB—lung cancer	6.25e-06	0.000298	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTA1—lung cancer	6.23e-06	0.000297	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCC3—lung cancer	6.16e-06	0.000294	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKR1C1—lung cancer	5.97e-06	0.000284	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CNDP2—lung cancer	5.88e-06	0.00028	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM2—lung cancer	5.88e-06	0.00028	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UGT1A1—lung cancer	5.79e-06	0.000276	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTMR3—lung cancer	5.72e-06	0.000273	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GNG11—lung cancer	5.59e-06	0.000266	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PGAM1—lung cancer	5.57e-06	0.000266	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDOA—lung cancer	5.32e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2A7—lung cancer	5.32e-06	0.000253	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SDC4—lung cancer	5.2e-06	0.000248	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA3—lung cancer	5.16e-06	0.000246	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCG2—lung cancer	5.02e-06	0.000239	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADCY1—lung cancer	5.02e-06	0.000239	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ENO2—lung cancer	4.93e-06	0.000235	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HPGDS—lung cancer	4.93e-06	0.000235	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPP2R1B—lung cancer	4.9e-06	0.000233	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTT1—lung cancer	4.78e-06	0.000228	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA3—lung cancer	4.74e-06	0.000226	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—RRM1—lung cancer	4.74e-06	0.000226	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GCLC—lung cancer	4.72e-06	0.000225	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2A6—lung cancer	4.72e-06	0.000225	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ENO1—lung cancer	4.48e-06	0.000213	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—B4GALT5—lung cancer	4.46e-06	0.000212	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA4—lung cancer	4.33e-06	0.000207	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA2—lung cancer	4.22e-06	0.000201	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTA1—lung cancer	4.07e-06	0.000194	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCC3—lung cancer	4.03e-06	0.000192	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2E1—lung cancer	4.02e-06	0.000191	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NQO1—lung cancer	3.97e-06	0.000189	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKR1C1—lung cancer	3.9e-06	0.000186	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UGT1A1—lung cancer	3.79e-06	0.000181	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GNG11—lung cancer	3.65e-06	0.000174	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—STK11—lung cancer	3.58e-06	0.000171	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDOA—lung cancer	3.48e-06	0.000166	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA3—lung cancer	3.38e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTP1—lung cancer	3.31e-06	0.000158	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADCY1—lung cancer	3.28e-06	0.000157	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCG2—lung cancer	3.28e-06	0.000157	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CAT—lung cancer	3.22e-06	0.000154	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ENO2—lung cancer	3.22e-06	0.000153	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HPGDS—lung cancer	3.22e-06	0.000153	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPP2R1B—lung cancer	3.2e-06	0.000153	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCB1—lung cancer	3.14e-06	0.000149	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTT1—lung cancer	3.12e-06	0.000149	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GCLC—lung cancer	3.09e-06	0.000147	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2A6—lung cancer	3.09e-06	0.000147	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TYMS—lung cancer	3.08e-06	0.000147	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM1—lung cancer	3.04e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ENO1—lung cancer	2.93e-06	0.00014	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A1—lung cancer	2.89e-06	0.000137	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ERCC2—lung cancer	2.86e-06	0.000136	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2E1—lung cancer	2.63e-06	0.000125	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NQO1—lung cancer	2.6e-06	0.000124	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—APOA1—lung cancer	2.48e-06	0.000118	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—STK11—lung cancer	2.34e-06	0.000112	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CG—lung cancer	2.26e-06	0.000108	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTP1—lung cancer	2.17e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—POMC—lung cancer	2.15e-06	0.000103	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CAT—lung cancer	2.11e-06	0.0001	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CREBBP—lung cancer	2.1e-06	9.99e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCB1—lung cancer	2.05e-06	9.77e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TYMS—lung cancer	2.01e-06	9.59e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM1—lung cancer	1.99e-06	9.48e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CD—lung cancer	1.99e-06	9.47e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—lung cancer	1.96e-06	9.35e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A1—lung cancer	1.89e-06	8.99e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ERCC2—lung cancer	1.87e-06	8.92e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CB—lung cancer	1.73e-06	8.25e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTGS2—lung cancer	1.72e-06	8.18e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—APOA1—lung cancer	1.62e-06	7.71e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTEN—lung cancer	1.5e-06	7.13e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CG—lung cancer	1.48e-06	7.04e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—EP300—lung cancer	1.43e-06	6.8e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—POMC—lung cancer	1.41e-06	6.7e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CREBBP—lung cancer	1.37e-06	6.53e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CD—lung cancer	1.3e-06	6.19e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—lung cancer	1.28e-06	6.11e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CB—lung cancer	1.13e-06	5.4e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTGS2—lung cancer	1.12e-06	5.35e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CA—lung cancer	1.06e-06	5.03e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTEN—lung cancer	9.78e-07	4.66e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—EP300—lung cancer	9.33e-07	4.45e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—lung cancer	8.62e-07	4.11e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CA—lung cancer	6.9e-07	3.29e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—lung cancer	5.64e-07	2.69e-05	CbGpPWpGaD
